Birmingham, West Midlands -- (SBWIRE) -- 10/24/2013 -- Value Penny Stocks issues special report on Dana Holding Corporation (NYSE:DAN), CIT Group Inc. (NYSE:CIT), Penn Virginia Corporation (NYSE:PVA), Myriad Genetics, Inc. (NASDAQ:MYGN).
Dana Holding Corporation (NYSE:DAN) opened its last trade at the price of $23.30. Its closing price was $22.86 after losing -1.97% for the day. The company traded with the total volume of 2,035,922 shares, while its average trading volume remained 1.47 million shares. The beta of this stock stands at 4.08. Dana Holding Corporation engages in the design, manufacture, and supply of driveline products, technologies, and service parts for vehicle manufacturers worldwide. The company operates in four segments: Vehicle Driveline Technologies, Commercial Vehicle Driveline Technologies, Off-Highway Driveline Technologies, and Power Technologies.
Has DAN Found The Bottom and Ready To Move Up? Find Out Here
CIT Group Inc. (NYSE:CIT) percentage change plunged -0.12% to close at $49.00 with the total traded volume of 2,012,615 shares, along with average volume of 1.25 million shares. The 52 week range of the stock remained $36.02 - $51.52, while its day lowest price was $47.88. The share price hit the day highest price of $49.11. CIT Group Inc. operates as the holding company for CIT bank that provides commercial financing and leasing products, as well as deposit products and savings accounts.
Has CIT Found The Bottom And Ready To Gain Momentum? Find Out Here
Penn Virginia Corporation (NYSE:PVA) traded on volume of 2,007,401 shares in the last session against average volume of 2.28 million shares. The company started its trading session with the price of $7.77 and closed at $7.46 by scoring -4.24%. Penn Virginia Corporation, an independent oil and gas company, engages in the exploration and development of natural gas and oil properties in various onshore regions of the United States.
Why Should Investors Buy PVA After the Recent Fall? Just Go Here and Find Out
Myriad Genetics, Inc. (NASDAQ:MYGN) started its last trading session with the price of $24.47 and closed at $25.39 by scoring +3.38%. The stock traded with total volume of 2,008,339 million shares, while the average trading volume remained 2.79 million shares. The beta value of this stock stands at 0.39. Day range for the stock was $24.40 - $25.43. Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States.
Why Should Investors Buy MYGN After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)